Cargando…

Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents

This study aimed to investigate whether the use of molecular-targeted agents could affect gastrointestinal (GI) toxicity in palliative radiotherapy (RT) for metastatic bone tumors in the abdominopelvic region. We collected data of patients who received palliative RT for bone metastases in the abdomi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Yuji, Kenjo, Masahiro, Ishikawa, Kazuki, Sakayauchi, Toru, Itasaka, Satoshi, Negoro, Yoshiharu, Jingu, Keiichi, Nishimura, Yasumasa, Nagata, Yasushi, Ogawa, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Regular Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336816/ https://www.ncbi.nlm.nih.gov/pubmed/32567666 http://dx.doi.org/10.1093/jrr/rraa035

Ejemplares similares

Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study
por: Takeda, Kazuya, et al.
Publicado: (2022)

A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10–2 trial)
por: Murofushi, Keiko Nemoto, et al.
Publicado: (2022)

What motivated medical students and residents to become radiation oncologists in Japan?—Questionnaire report by the radiotherapy promotion committee of JASTRO
por: Murakami, Yuji, et al.
Publicado: (2020)

Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer
por: Ueda, Hiroto, et al.
Publicado: (2017)

Long-Term Survival Following Palliative Chemoradiotherapy in an Elderly Patient With Advanced Squamous Cell Carcinoma in the Right Mandibular Gingiva
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
por: Umezawa, Rei, et al.
Publicado: (2011)

Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy
por: Kimura, Tomoki, et al.
Publicado: (2015)

The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
por: Kimura, Tomoki, et al.
Publicado: (2015)

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers
por: Kubo, Katsumaro, et al.
Publicado: (2020)

Uncertainty in the positioning of patients receiving treatment for brain metastases and wearing surgical mask underneath thermoplastic mask during COVID‐19 crisis
por: Miura, Hideharu, et al.
Publicado: (2021)

Hybrid volumetric-modulated arc therapy for postoperative breast cancer including regional lymph nodes: the advantage of dosimetric data and safety of toxicities
por: Doi, Yoshiko, et al.
Publicado: (2020)

Improved treatment robustness of postoperative breast cancer radiotherapy including supraclavicular nodes
por: Miura, Hideharu, et al.
Publicado: (2022)

Gastrointestinal Symptoms in Children With Life-Limiting Conditions Receiving Palliative Home Care
por: Hauch, Holger, et al.
Publicado: (2021)

Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies
por: Kimura, Tomoki, et al.
Publicado: (2018)

Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)
por: Inada, Masahiro, et al.
Publicado: (2022)

MRI appearance change during stereotactic radiotherapy for large brain metastases and importance of treatment plan modification during treatment period
por: Kubo, Katsumaro, et al.
Publicado: (2019)

Impact on liver position under breath-hold by computed tomography contrast agents in stereotactic body radiotherapy of liver cancer
por: Miura, Hideharu, et al.
Publicado: (2021)

Volumetric-Modulated Arc Therapy for Giant-Cell Tumor of Temporal Bone: An Illustrative Case Report
por: Kubo, Katsumaro, et al.
Publicado: (2022)

Effect of Target Changes on Target Coverage and Dose to the Normal Brain in Fractionated Stereotactic Radiation Therapy for Metastatic Brain Tumors
por: Miura, Hideharu, et al.
Publicado: (2023)

Symptoms of total pain experienced by older people with advanced gastrointestinal cancer receiving palliative chemotherapy
por: Jespersen, Eva, et al.
Publicado: (2022)

Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer
por: Takeda, Kazuya, et al.
Publicado: (2023)

Organ-preserving approach via radiotherapy for small cell carcinoma of the bladder: an analysis based on the Japanese Radiation Oncology Study Group (JROSG) survey
por: Akamatsu, Hiroko, et al.
Publicado: (2019)

Efficacy of intraoperative radiotherapy targeted to the abdominal lymph node area in patients with esophageal carcinoma
por: Tamaki, Yukihisa, et al.
Publicado: (2012)

Hydrogel spacer shrinkage during external-beam radiation therapy following low-dose-rate brachytherapy for high-risk prostate cancer: a case series
por: Kubo, Katsumaro, et al.
Publicado: (2021)

Dosimetric Evaluation of Simplified Knowledge-Based Plan with an Extensive Stepping Validation Approach in Volumetric-Modulated Arc Therapy-Stereotactic Body Radiotherapy for Lung Cancer
por: Wada, Yutaro, et al.
Publicado: (2021)

Effectiveness of robust optimization in volumetric modulated arc therapy using 6 and 10 MV flattening filter-free beam therapy planning for lung stereotactic body radiation therapy with a breath-hold technique
por: Miura, Hideharu, et al.
Publicado: (2020)

Comparison of the effects of radiotherapy doses of 50.4 Gy and 60 Gy on outcomes of chemoradiotherapy for thoracic esophageal cancer: subgroup analysis based on the Comprehensive Registry of Esophageal Cancer in Japan from 2009 to 2011 by the Japan Esophageal Society
por: Nemoto, Kenji, et al.
Publicado: (2020)

Dose–volume histogram analysis and clinical evaluation of knowledge-based plans with manual objective constraints for pharyngeal cancer
por: Uehara, Takuya, et al.
Publicado: (2020)

A prospective clinical trial of tumor hypoxia imaging with (18)F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy
por: Tachibana, Izumi, et al.
Publicado: (2013)

Successful palliation for an aged patient with primary pericardial mesothelioma
por: Isoda, Ryutaro, et al.
Publicado: (2015)

Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2017)

A long-term survival case with proton beam therapy for advanced sphenoid sinus cancer with hypopituitarism
por: Ishikawa, Yojiro, et al.
Publicado: (2021)

Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Successful treatment with proton beam therapy for a solitary sternal metastasis of breast cancer: a case report
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Palliation in Gallbladder Cancer: The Role of Gastrointestinal Endoscopy
por: Schepis, Tommaso, et al.
Publicado: (2022)

Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy
por: Anami, Shimpei, et al.
Publicado: (2019)

Quality of Life in Cancer Patients Receiving Palliative Care
por: Singh, Divya Pal
Publicado: (2010)

Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil
por: Matsunaga, Tomoyuki, et al.
Publicado: (2021)

A Case of KIT-Negative Extra-Gastrointestinal Stromal Tumor of the Lesser Omentum
por: Ogawa, Hisataka, et al.
Publicado: (2012)

Cholecyst-jejunostomy for palliative surgery
por: Kogo, Hideki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qqjhnqko89cp1ssd7lri5ast7u